Leizhen Zheng

机构：Shanghai Jiao Tong University, XinHua Hospital · ORCID：0000-0003-1309-3755

发表论文 55 篇 · 总被引 4174 次 · h-index 22

代表论文

• Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study (2017 · Journal of Hematology & Oncology · 被引 84)
• Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients (2018 · Cancer Management and Research · 被引 82)
• Depression and survival of glioma patients: A systematic review and meta-analysis (2018 · Clinical Neurology and Neurosurgery · 被引 77)
• The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation (2018 · Journal of Experimental & Clinical Cancer Research · 被引 61)
• GPR120 induces regulatory dendritic cells by inhibiting HK2-dependent glycolysis to alleviate fulminant hepatic failure (2021 · Cell Death and Disease · 被引 47)
• Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer (2022 · Journal of the National Cancer Center · 被引 28)